Global Medical Bioactive Glass Market Growth 2025-2031

The global Medical Bioactive Glass market size is predicted to grow from US$ 439 million in 2025 to US$ 578 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.

Medical Bioactive Glass is a kind of material that can repair, replace and regenerate body tissues and form bonds between tissues and materials.

North America is the biggest market, holds a share about 60%, followed by Europe with about 35% share. Medical bioactive glass products are mainly used in bone materials, dental materials and cosmetics. The bone materials holds the largest market share about 57%, followed by dental materials, which have a share about 22%. The Major global manufacturers include Zimmer Biomet Holdings, Inc., Stryker, SCHOTT, BonAlive Biomaterials and NovaBone, etc. And the major global manufacturers hold a share over 84%.

LP Information, Inc. (LPI) ' newest research report, the “Medical Bioactive Glass Industry Forecast” looks at past sales and reviews total world Medical Bioactive Glass sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Bioactive Glass sales for 2025 through 2031. With Medical Bioactive Glass sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Bioactive Glass industry.

This Insight Report provides a comprehensive analysis of the global Medical Bioactive Glass landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Bioactive Glass portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Bioactive Glass market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Bioactive Glass and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Bioactive Glass.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Bioactive Glass market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
45S5
S53P4
Others

Segmentation by Application:
Bone Materials
Dental Materials
Cosmetics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zimmer Biomet Holdings, Inc.
Stryker
SCHOTT
BonAlive Biomaterials
NovaBone
Beijing Xinfuyisheng High Technology
Prosidyan
Ferro
Mo-Sci Corporation
Synergy Biomedical
3M
Matexcel
Noraker
Ugulin
Kunshan Overseas Chinese Technology New Materials
Zhangjiagang Lanzhi Biotechnology
Guangzhou Kejin Material Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Bioactive Glass market?

What factors are driving Medical Bioactive Glass market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Bioactive Glass market opportunities vary by end market size?

How does Medical Bioactive Glass break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.